Pharmacy

The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week.

Hospitals are failing to fulfill the promise of the 340B program, which offers discounted drugs to hospitals that treat a large proportion of underinsured and uninsured patients, The Wall Street Journal reported Dec. 20. 

As demand for a popular flu drug increases during the worst flu season in more than a decade, HHS expanded access to Tamiflu on Dec. 21 through the Strategic National Stockpile. 

As drugmakers prepare for the government to stop paying for their COVID-19 treatments, the value of Pfizer's popular COVID-19 drug Paxlovid has decreased by more than 80 percent, according to the Institute for Clinical and Economic Review. 

From its plan to acquire Summit Health to its robot-powered fulfillment centers, and from its $5 billion settlement for opioid cases to reforming its worker evaluation practices, here are Walgreens' biggest moves in 2022 listed in order of Becker's coverage. 

Chantal Friebertshäuser, a former executive at Merck and Eli Lilly, will join Moderna as the senior vice president of commercial, Europe, Middle East and Canada, effective Jan. 1. 

Pharmacists will be listed as providers on some U.S. government employees' insurance bills for their roles in assessing COVID-19 symptoms and prescribing the antiviral Paxlovid. 

The two largest pharmacy retailers are restricting orders for some pediatric pain medications as healthcare battles a strong season of flu, respiratory syncytial virus and COVID-19 cases, The Hill reported Dec. 19. 

The Drug Enforcement Administration may revoke TruePill's ability to fill controlled substances over allegations that it wrongly filled thousands of prescriptions for stimulants used to treat attention-deficit/hyperactivity disorder. 

The FDA added Eli Lilly's diabetes drugs Mounjaro and Trulicity to its list of medications in short supply Dec. 15.